Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors

被引：0
|
作者：
Matthew E. Hardee
Rose J. Eapen
Zahid N. Rabbani
Matthew R. Dreher
Jeffrey Marks
Kimberly L. Blackwell
Mark W. Dewhirst
机构：
[1] Duke University Medical Center,Department of Pathology
[2] University of North Carolina Medical Center,Department of Otolaryngology
[3] Duke University Medical Center,Department of Radiation Oncology
[4] National Institutes of Health Clinical Center,Department of Diagnostic Radiology
[5] Duke University Medical Center,Department of Surgery
[6] Duke University Medical Center,Department of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 63卷
关键词：
Her2/neu; Angiogenesis; Tumor hypoxia; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：219 / 228
页数：9
相关论文
共 50 条
  • [1] Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors
    Hardee, Matthew E.
    Eapen, Rose J.
    Rabbani, Zahid N.
    Dreher, Matthew R.
    Marks, Jeffrey
    Blackwell, Kimberly L.
    Dewhirst, Mark W.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (02) : 219 - 228
  • [2] DCIS and HER2/neu
    Tulusan, AH
    [J]. ONKOLOGIE, 2002, 25 : 11 - 12
  • [3] HER2/neu expression in malignant lung tumors
    Hirsch, FR
    Franklin, WA
    Veve, R
    Varella-Garcia, M
    Bunn, PA
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (01) : 51 - 58
  • [4] Phosphoproteomic analysis of Her2/neu signaling and inhibition
    Bose, Ron
    Molina, Henrik
    Patterson, A. Scott
    Bitok, John K.
    Periaswamy, Balamurugan
    Bader, Joel S.
    Pandey, Akhilesh
    Cole, Philip A.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (26) : 9773 - 9778
  • [5] Phosphoproteomic analysis of Her2/neu signaling and inhibition
    Bose, Ron
    Molina, Henrik
    Bitok, John K.
    Bader, Joel S.
    Pandey, Akhilesh
    Cole, Philip A.
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [6] Serum HER2/neu levels in breast cancer patients with different level of tumor HER2/neu protein expression
    Kushlinsky, Nicolai
    Gershtein, Elena
    Shyroky, Vyacheslav
    Ermilova, Valeriya
    Tchemeris, Galina
    Letyagin, Victor
    [J]. TUMOR BIOLOGY, 2007, 28 : 95 - 95
  • [7] Role of HER2/neu in tumor progession and therapy
    Ménard, S
    Casalini, P
    Campiglio, M
    Pupa, SM
    Tagliabue, E
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (23) : 2965 - 2978
  • [8] Activating Mutations in HER2: Neu Opportunities and Neu Challenges
    Weigelt, Britta
    Reis-Filho, Jorge S.
    [J]. CANCER DISCOVERY, 2013, 3 (02) : 145 - 147
  • [9] A novel nanobioconjugate for the treatment of HER2/neu expressing tumors
    Helguera, Gustavo
    Rodriguez, Jose
    Ding, Hui
    Inoue, Satoshi
    Patil, Rameshawar
    Holler, Eggehard
    Black, Keith
    Ljubimova, Julia
    Penichet, Manuel
    [J]. CANCER RESEARCH, 2009, 69
  • [10] Dysregulation of cellular signaling by HER2/neu in breast cancer
    Zhou, BP
    Hung, MC
    [J]. SEMINARS IN ONCOLOGY, 2003, 30 (05) : 38 - 48
12345